SCHEMBL2197156

SCHEMBL2197156

FC(F)(F)Sc1ccccc1NNc1ccccc1SC(F)(F)F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 4/20 0.51
▸ ALDH1A1 P00352 3/20 0.51
▸ HTT P42858 2/20 0.51
▸ PKM P14618 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ PTPN1 P18031 2/20 0.38
▸ PTPRZ1 P23471 2/20 0.38
▸ MAPT P10636 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ ALOX5AP P20292 1/20 0.36
▸ FEN1 P39748 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ KCNK2 O95069 1/20 0.36
▸ KCNK10 P57789 1/20 0.36
▸ KMT2A Q03164 1/20 0.35
▸ LMNA P02545 1/20 0.34
▸ FFAR4 Q5NUL3 1/20 0.34
▸ CCR2 P41597 1/20 0.34
▸ TDP1 Q9NUW8 2/20 0.33
▸ HCAR1 Q9BXC0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2770730 0.81 L3MBTL1 (0.52) L3MBTL1ALDH1A1HTTPKMHPGD
SCHEMBL1275186 0.79 L3MBTL1 (0.46) L3MBTL1ALDH1A1HTTPKMHPGD
SCHEMBL10502933 0.71 ALDH1A1 (0.42) L3MBTL1ALDH1A1HTTPKMHPGD
SCHEMBL1958637 0.71 ALDH1A1 (0.39) L3MBTL1ALDH1A1HTTPKMHPGD
SCHEMBL3831544 0.71 HTR7 (0.39) L3MBTL1ALDH1A1HTTPKMHPGD
SCHEMBL525897 0.71 ALDH1A1 (0.42) L3MBTL1ALDH1A1HTTPKMHPGD
SCHEMBL31171603 0.71 HTR7 (0.39) L3MBTL1ALDH1A1HTTPKMHPGD
SCHEMBL3542339 0.70 ALDH1A1 (0.41) L3MBTL1ALDH1A1HTTPKMHPGD
SCHEMBL476655 0.70 ALDH1A1 (0.38) L3MBTL1ALDH1A1HTTPKMHPGD
SCHEMBL10503317 0.70 L3MBTL1 (0.41) L3MBTL1ALDH1A1HTTPKMHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8507473-B2 3H-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of GPR81 receptor disorders ARENA PHARMACEUTICALS, INC. (US) 2013-08-13 — — US disclosed
US-20110172209-A1 3H-IMIDAZO[4,5-B]PYRIDIN-5-OL DERIVATIVES USEFUL IN THE TREATMENT OF GPR81 RECEPTOR DISORDERS ARENA PHARMACEUTICALS, INC. (US) 2011-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172209-A1 3H-IMIDAZO[4,5-B]PYRIDIN-5-OL DERIVATIVES USEFUL IN THE TREATMENT OF GPR81 RECEPTOR DISORDERS GPR84, GPR119, GPR65 L3MBTL1 4688/4885ALDH1A1 725/4885HTT 4377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback